--- title: "CAINA and others established a new technology company in Shanghai" type: "News" locale: "en" url: "https://longbridge.com/en/news/247901840.md" description: "According to the Qichacha APP, recently, CAINA Jiacheng Technology Co., Ltd. was established, with Yan Qun as the legal representative. The business scope includes: sales of laboratory analytical instruments; sales of special equipment; sales of testing machines; sales of intelligent instruments and meters, etc. Qichacha's equity penetration shows that the company is jointly held by CAINA and others" datetime: "2025-07-10T01:30:11.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/247901840.md) - [en](https://longbridge.com/en/news/247901840.md) - [zh-HK](https://longbridge.com/zh-HK/news/247901840.md) generator: "portal-rs" --- # CAINA and others established a new technology company in Shanghai According to the Qichacha APP, recently, CAINA Jiacheng Technology Co., Ltd. was established, with Yan Qun as the legal representative. The business scope includes: sales of experimental analysis instruments; sales of special equipment; sales of testing machines; sales of intelligent instruments and meters, etc. Qichacha's equity penetration shows that the company is jointly held by CAINA and others ### Related Stocks - [301122.CN](https://longbridge.com/en/quote/301122.CN.md) ## Related News & Research - [08:15 ETNow's the Time: Late Summer Is the Best Season For Homebuyers to Score a Deal in These U.S. Metros](https://longbridge.com/en/news/296616885.md) - [FDA Gives Marketing Authorization to Vitestro's Robotic Blood Draw Device](https://longbridge.com/en/news/296405953.md) - [Thales, Systematic partner to boost Danish air defense capabilities](https://longbridge.com/en/news/296363485.md) - [Zephyr Introduces the Presrv™ Gourmet Clear Ice Machine](https://longbridge.com/en/news/296352842.md) - [Dicot Pharma submits EU clinical trial application for LIB-01 phase 2b study](https://longbridge.com/en/news/296068059.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**